Interestingly, all of the patients (N=11) having EGFR tumour expression detected by immunohistochemistry together with low levels of both serum EGF (<667 pg ml−1) and TGF-α (<14 pg ml−1) showed a response. The gene discussed is EGF; the disease is neoplasm.